Visterra Inc.

About Visterra Inc.

Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our proprietary technology platform enables the design and engineering of precision antibody-based product candidates that specifically bind to, and modulate, key disease targets.


Information Technology

June 2020 - August 2020 Waltham, MA
“Working with computers.”
See All